#failure-rates

#failure-rates

Median costs of drug development are often cited inaccurately, as high-cost developments skew the average. The median cost is actually around a third of the cited amount.

Since ChatGPT emerged in November 2022, venture capitalist investments in AI have skyrocketed, rising to $131.5 billion in 2024, an increase of 52 percent compared to 2023.